Tersolisib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tersolisib, covering 2026-04-17 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors [Phase 1, Phase 2]